Genocea Biosciences (GNCA) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock GNCA vs. SMFL, SCPS, EVLO, CMRA, GNCAQ, ARDS, CALA, STAB, AMPE, and EFTRShould you be buying Genocea Biosciences stock or one of its competitors? The main competitors of Genocea Biosciences include Smart for Life (SMFL), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Aridis Pharmaceuticals (ARDS), Calithera Biosciences (CALA), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry. Genocea Biosciences vs. Smart for Life Scopus BioPharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Aridis Pharmaceuticals Calithera Biosciences Statera Biopharma Ampio Pharmaceuticals eFFECTOR Therapeutics Genocea Biosciences (NASDAQ:GNCA) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations, community ranking and profitability. Which has more volatility and risk, GNCA or SMFL? Genocea Biosciences has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Which has better earnings & valuation, GNCA or SMFL? Smart for Life has higher revenue and earnings than Genocea Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenocea Biosciences$1.91M0.00-$33.20M-$0.61N/ASmart for Life$11.11M0.00-$22.68MN/AN/A Is GNCA or SMFL more profitable? Smart for Life's return on equity of 0.00% beat Genocea Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Genocea BiosciencesN/A -182.88% -62.76% Smart for Life N/A N/A N/A Does the MarketBeat Community favor GNCA or SMFL? Genocea Biosciences received 387 more outperform votes than Smart for Life when rated by MarketBeat users. However, 100.00% of users gave Smart for Life an outperform vote while only 55.75% of users gave Genocea Biosciences an outperform vote. CompanyUnderperformOutperformGenocea BiosciencesOutperform Votes38855.75% Underperform Votes30844.25% Smart for LifeOutperform Votes1100.00% Underperform VotesNo Votes Does the media favor GNCA or SMFL? In the previous week, Genocea Biosciences had 2 more articles in the media than Smart for Life. MarketBeat recorded 2 mentions for Genocea Biosciences and 0 mentions for Smart for Life. Genocea Biosciences' average media sentiment score of 0.00 equaled Smart for Life'saverage media sentiment score. Company Overall Sentiment Genocea Biosciences Neutral Smart for Life Neutral Do insiders and institutionals have more ownership in GNCA or SMFL? 0.6% of Genocea Biosciences shares are held by institutional investors. Comparatively, 28.4% of Smart for Life shares are held by institutional investors. 1.6% of Genocea Biosciences shares are held by company insiders. Comparatively, 31.7% of Smart for Life shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummarySmart for Life beats Genocea Biosciences on 7 of the 10 factors compared between the two stocks. Get Genocea Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GNCA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNCA vs. The Competition Export to ExcelMetricGenocea BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$6,000.00$2.84B$5.30B$7.34BDividend YieldN/A1.86%5.45%4.30%P/E Ratio0.0030.4821.8617.80Price / SalesN/A441.91380.5297.73Price / CashN/A168.6838.2634.64Price / BookN/A3.466.453.98Net Income-$33.20M-$72.06M$3.22B$247.81M Genocea Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070SMFLSmart for LifeN/A$0.00-27.8%N/A-100.0%$18,000.00$11.11M0.00110Gap DownSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9,000.00N/A0.00120Options VolumeNews CoverageCMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5,000.00$3.09M0.0030CALACalithera BiosciencesN/A$0.00flatN/A-80.0%$5,000.00N/A0.0060Analyst ForecastNews CoverageSTABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020AMPEAmpio PharmaceuticalsN/A$0.00+250.0%N/A-99.1%$2,000.00N/A0.0020Analyst ForecastNews CoverageGap UpEFTReFFECTOR TherapeuticsN/A$0.00flatN/A-100.0%$1,000.00$3.55M0.0010 Related Companies and Tools Related Companies SMFL Competitors SCPS Competitors EVLO Competitors CMRA Competitors GNCAQ Competitors ARDS Competitors CALA Competitors STAB Competitors AMPE Competitors EFTR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GNCA) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genocea Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
